Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran∗∗Orgalutran, NV Organon, Oss, the Netherlands.). part I. absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers-Reference-Cited by-同舟云学术

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran∗∗Orgalutran, NV Organon, Oss, the Netherlands.). part I. absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

Published:1999-12 Issue:6 Volume:72 Page:1001-1005
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Oberyé Janine J.L,Mannaerts Bernadette M.J.L,Kleijn Huub-Jan,Timmer Cees J

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference12 articles.

1. Gonadotropin-releasing hormone and its analogs;Conn;Annu Rev Med,1994

2. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon);Hum Reprod,1998

3. Pharmacokinetics and pharmacodynamics of a novel GnRH antagonist (RS-26306) in humans;Shah;Pharm Res,1991

4. Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (ganirelix) with minimal histamine-releasing properties;Rabinovici;J Clin Endocrinol Metab,1992

5. Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix);Nelson;Fertil Steril,1995

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives;Expert Opinion on Pharmacotherapy;2023-08-24

2. Testosterone-associated blood pressure dysregulation in women with androgen excess polycystic ovary syndrome;American Journal of Physiology-Heart and Circulatory Physiology;2023-08-01

3. Ganirelix and the prevention of premature luteinizing hormone surges;F&S Reports;2023-06

4. Sex Hormones and Environmental Factors Affecting Exercise;Sex Hormones, Exercise and Women;2023

5. Efficacy and safety of newly developed ganirelix acetate in infertile women for assisted reproductive technology: a prospective, randomised, controlled study;Journal of Obstetrics and Gynaecology;2022-03-07